Log in

NASDAQ:LIFEaTyr Pharma Earnings Date, Estimates & History

$2.90
+0.34 (+13.28 %)
(As of 04/5/2020 04:00 PM ET)
Add
Compare
Today's Range
$2.40
Now: $2.90▼
$2.97
50-Day Range
$2.17
MA: $3.41▼
$4.37
52-Week Range
$2.13
Now: $2.90▼
$10.08
Volume140,023 shs
Average Volume143,657 shs
Market Capitalization$11.28 million
P/E RatioN/A
Dividend YieldN/A
Beta2.25

Earnings

aTyr Pharma (NASDAQ:LIFE) Earnings Information

aTyr Pharma last announced its earnings data on March 26th, 2020. The biotechnology company reported ($1.54) earnings per share (EPS) for the quarter, beating the consensus estimate of ($1.59) by $0.05. The company earned $0.14 million during the quarter, compared to analysts' expectations of $0.09 million. aTyr Pharma has generated ($7.03) earnings per share over the last year. aTyr Pharma has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 11th, 2020 based off prior year's report dates.

aTyr Pharma Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

aTyr Pharma (NASDAQ:LIFE) Earnings Estimates

2020 EPS Consensus Estimate: ($2.91)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20201$0.05$0.05$0.05
Q2 20201($0.96)($0.96)($0.96)
Q3 20201($0.99)($0.99)($0.99)
Q4 20201($1.01)($1.01)($1.01)

aTyr Pharma (NASDAQ LIFE) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
5/11/2020
(Estimated)		       
3/26/202012/31/2019($1.59)($1.54)($1.54)$0.09 million$0.14 millionTranscript
11/14/2019Q3 2019($1.43)($1.47)($1.47)$0.06 million$0.18 millionTranscript
8/14/2019Q2 2019($2.74)($1.80)($1.80)$0.09 millionN/A
5/13/20193/31/2019($3.22)($2.52)($0.18)Transcript
3/25/2019Q4($3.0380)($2.94)($0.21)Transcript
11/13/2018Q3 2018($4.20)($3.36)($0.24)N/A
8/14/2018Q2 2018($4.76)($4.90)($0.35)N/A
5/14/2018Q1($4.90)($5.04)($0.36)Transcript
3/19/2018Q4 2017($6.02)($5.46)($0.39)N/A
11/14/2017Q3 2017($7.00)($6.02)($0.43)N/A
8/14/2017Q2 2017($7.98)($7.14)($0.51)N/A
5/11/2017Q1 2017($6.9580)($7.84)($0.56)N/A
3/16/2017Q4 2016($8.54)($7.42)($0.53)N/A
11/14/2016Q3 2016($9.38)($8.12)($0.58)N/A
8/10/2016Q216($9.94)($9.10)($0.65)N/A
5/11/2016Q1($9.80)($9.52)($0.68)N/A
3/30/2016Q4($7.28)($9.80)($0.70)N/A
11/10/2015Q3($6.72)($6.72)($0.48)N/A
8/12/2015Q215($7.42)($10.36)($0.74)N/A
6/18/2015Q115($5.74)($5.32)($0.38)N/A
11/5/2013Q313$13.58$14.28$926.10 million$936.00 millionN/A
7/31/2013Q2 2013$13.44$10.08$952.06 million$944.00 millionTranscript
5/2/2013Q1 2013$14.56$14.98$958.56 million$963.00 millionTranscript
2/4/2013Q4 2012$15.54$15.54$988.85 million$998.90 millionTranscript
11/1/2012Q312$12.46$12.88$907.91 million$911.00 millionN/A
7/31/2012$13.58$13.44N/A
2/7/2012$14.56$14.84N/A
10/25/2011$12.32$13.16N/A
7/28/2011$13.30$12.46N/A
4/26/2011$11.90$11.90N/A
2/3/2011$12.18$12.60N/A
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 4/5/2020 by MarketBeat.com Staff

Featured Article: What are the benefits of a balanced fund?
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel